Diverticulitis

Colon Rectal MD Announces New Robotic Colorectal Surgery Practice in Broward County

Retrieved on: 
月曜日, 4月 29, 2024
Colorectal surgery, Ulcerative colitis, Abscess, Colorectal cancer, Crohn's disease, General surgery, Suite, Hemorrhoid, Diverticulitis, Cancer, Fecal incontinence, Inflammatory bowel disease, Patient, Rectal prolapse, Colonoscopy, Anal, Diagnosis, Patient satisfaction, Quality of life, Gallbladder disease, Hospital

FORT LAUDERDALE, Fla., April 29, 2024 /PRNewswire-PRWeb/ -- Dr. Astha Bhatt, a leading board-certified general surgeon and fellowship-trained specialist in Minimally Invasive Colorectal surgery. We announce the opening of her new practice, Colon Rectal MD, in Broward County, Florida. Dr. Bhatt's practice focuses on providing personalized care utilizing the latest in robotic and laparoscopic technology.

Key Points: 
  • We announce the opening of her new practice, Colon Rectal MD, in Broward County, Florida.
  • Dr. Bhatt's practice focuses on providing personalized care utilizing the latest in robotic and laparoscopic technology.
  • Colon Rectal MD distinguishes itself by utilizing the da Vinci robotic system, enhancing surgical accuracy and facilitating faster patient recovery.
  • This advanced approach places Dr. Bhatt at the forefront of colorectal surgery, and general surgery particularly in treating Colon Cancer, Rectal Cancer, pelvic floor disorders, and inflammatory bowel disease.

Reese Pharmaceutical Launches New At-Home Colon Cancer Screening Test

Retrieved on: 
火曜日, 2月 27, 2024
American Cancer Society, Woman, Colorectal cancer, Colonoscopy, Blood, FDA, OTC, Cough, Food, Pharmacy, Polyp, Sale, FIT, Diverticulitis, Fecal immunochemical test, Cancer, Food and Drug Administration, Colitis, Insurance, Pharmaceutical industry

CLEVELAND, Feb. 27, 2024 /PRNewswire/ -- Reese Pharmaceutical is expanding its over-the-counter (OTC) diagnostic portfolio with the launch of ColoTest®, an at-home Fecal Immunochemical Test (FIT) that identifies the presence of hidden blood in the stool in support of the early detection of colon cancer or gastrointestinal disorders such as colitis, diverticulitis, and polyps.

Key Points: 
  • A recent report by the American Cancer Society revealed a troubling spike in new colon and rectal cancer diagnoses across the US.
  • "90% of colon cancer-related deaths are thought to be preventable if caught early, and yet more than 29 million Americans are not screening for it.
  • With colon cancer rates on the rise, it is more important than ever for people to be proactive.
  • This test is performed in the comfort of your own home with results at home as soon as 1 minute," said Jeffrey Reese, President, of Reese Pharmaceutical.

Harvard Apparatus Regenerative Technology and the McGowan Institute for Regenerative Medicine at the University of Pittsburgh Establish a Research Collaboration to Study the Repair and Regeneration of the Colon following Colectomy

Retrieved on: 
月曜日, 12月 18, 2023
Necrosis, Risk, Infection, Human, Inflammatory bowel disease, DRS, Disease, SRA, Harvard Apparatus, Colectomy, Cancer, Abdomen, University, UPMC, OTCQB, Regenerative medicine, Diverticulitis, Patient

Stephen Badylak, George Hussey and Vincent Anto at the McGowan Institute for Regenerative Medicine, a center of the University of Pittsburgh and UPMC focused on developing regenerative therapies to address organ and tissue failure.

Key Points: 
  • Stephen Badylak, George Hussey and Vincent Anto at the McGowan Institute for Regenerative Medicine, a center of the University of Pittsburgh and UPMC focused on developing regenerative therapies to address organ and tissue failure.
  • The program will focus on the use of Harvard Apparatus Regenerative Technology’s cell-based scaffold platform to repair the colon following colon resection in a rodent model of colectomy.
  • Developing a product to repair and/or regenerate the colon following colectomy will expand our pipeline and further our product portfolio for repairing and regenerating tubular organs within the gastrointestinal tract”, commented Jerry He, Harvard Apparatus Regenerative Technology 's Chief Executive Officer.
  • “The program is designed to test several versions of our cell-based scaffold technology to repair tubular organs in the digestive system.

Redefining Colorectal Cancer (CRC) Landscape Report with DLI's Epidemiology Study, Drug Insights, Price Reimbursement, and Regulatory Consulting Services | Disease Landscape Insights

Retrieved on: 
月曜日, 10月 9, 2023
Carcinoid, CT, Diverticulitis, Smoking, Manga: The Complete Guide, Gist, Anemia, Human, Epidemiology, Weight loss, Rectum, Lymphoma, Sarcoma, Breast cancer, Market intelligence, Radiation, CRC, Disease, Colonoscopy, Cancer, Myth, EMA, FDA, Weakness, Environment, Signs and symptoms, Fatigue, Elijah Cummings Lower Drug Costs Now Act, Colorectal cancer, HPV, Colon, Stromal cell, Scrub typhus, Compensation, Blood, DLI, Patient, Pharmaceutical industry, Medical imaging, Dietary supplement, Vaccine, Pneumonia

The diagnostic landscape of this disease is diverse wherein colonoscopy recommendations are given by doctors due to its accuracy.

Key Points: 
  • The diagnostic landscape of this disease is diverse wherein colonoscopy recommendations are given by doctors due to its accuracy.
  • Apart from that ct scan colon cancer and ct scan for bowel cancer, may also be suggested for the detection of colorectal malignant neoplasm.
  • It has been assisting them with regulatory consulting, pharma consulting services, post launch strategies, product pipeline assessment, and treatment gaps identification.
  • Find out more about Tonsillitis symptoms, consulting services, drug costs, FDA-approved medications, disease landscape, regulatory insights, epidemiology, and price reimbursement.

Redefining Colorectal Cancer (CRC) Landscape Report with DLI's Epidemiology Study, Drug Insights, Price Reimbursement, and Regulatory Consulting Services | Disease Landscape Insights

Retrieved on: 
月曜日, 10月 9, 2023
Carcinoid, CT, Diverticulitis, Smoking, Manga: The Complete Guide, Gist, Anemia, Human, Epidemiology, Weight loss, Rectum, Lymphoma, Sarcoma, Breast cancer, Market intelligence, Radiation, CRC, Disease, Colonoscopy, Cancer, Myth, EMA, FDA, Weakness, Environment, Signs and symptoms, Fatigue, Elijah Cummings Lower Drug Costs Now Act, Colorectal cancer, HPV, Colon, Stromal cell, Scrub typhus, Compensation, Blood, DLI, Patient, Pharmaceutical industry, Medical imaging, Dietary supplement, Vaccine, Pneumonia

The diagnostic landscape of this disease is diverse wherein colonoscopy recommendations are given by doctors due to its accuracy.

Key Points: 
  • The diagnostic landscape of this disease is diverse wherein colonoscopy recommendations are given by doctors due to its accuracy.
  • Apart from that ct scan colon cancer and ct scan for bowel cancer, may also be suggested for the detection of colorectal malignant neoplasm.
  • It has been assisting them with regulatory consulting, pharma consulting services, post launch strategies, product pipeline assessment, and treatment gaps identification.
  • Find out more about Tonsillitis symptoms, consulting services, drug costs, FDA-approved medications, disease landscape, regulatory insights, epidemiology, and price reimbursement.

Bioinformatics Market Size is Projected to Hit 24.07 Bn by 2028, With at a 12.1% CAGR by 2022-2028 | Brandessence Market Research

Retrieved on: 
火曜日, 9月 26, 2023
The Comprehensive Guide to Board Wargaming, Data management, Database, DNA, Drug development, Information technology, Genetics, Genomics, Diverticulitis, Personal Data Privacy and Security Act of 2009, Privacy, Bioinformatics, Research, Thermo Fisher Scientific, Confidentiality, Proteomics, Nanopore sequencing, Drug, Security, EMA, Data analysis, Investment, Mining, Anemia, Drug discovery, HPV, Porter's five forces analysis, Growth, FDA, Epidemiology, Software, Risk management, Pharmaceutical industry, Network equipment provider, Video game, Vaccine, Illumina, Qiagen

The escalating demand for integrated bioinformatics systems in proteomics and genomics is also bolstering market growth.

Key Points: 
  • The escalating demand for integrated bioinformatics systems in proteomics and genomics is also bolstering market growth.
  • However, challenges persist in the form of a shortage of skilled professionals and the high implementation costs associated with bioinformatics software.
  • Competitive Rivalry within the Industry:
    High Threat: The bioinformatics market is highly competitive, with numerous well-established players vying for market share.
  • The bioinformatics market is poised for remarkable growth, driven by technological advancements, increasing research endeavors, and a burgeoning focus on personalized medicine.

Bioinformatics Market Size is Projected to Hit 24.07 Bn by 2028, With at a 12.1% CAGR by 2022-2028 | Brandessence Market Research

Retrieved on: 
火曜日, 9月 26, 2023
The Comprehensive Guide to Board Wargaming, Data management, Database, DNA, Drug development, Information technology, Genetics, Genomics, Diverticulitis, Personal Data Privacy and Security Act of 2009, Privacy, Bioinformatics, Research, Thermo Fisher Scientific, Confidentiality, Proteomics, Nanopore sequencing, Drug, Security, EMA, Data analysis, Investment, Mining, Anemia, Drug discovery, HPV, Porter's five forces analysis, Growth, FDA, Epidemiology, Software, Risk management, Pharmaceutical industry, Network equipment provider, Video game, Vaccine, Illumina, Qiagen

The escalating demand for integrated bioinformatics systems in proteomics and genomics is also bolstering market growth.

Key Points: 
  • The escalating demand for integrated bioinformatics systems in proteomics and genomics is also bolstering market growth.
  • However, challenges persist in the form of a shortage of skilled professionals and the high implementation costs associated with bioinformatics software.
  • Competitive Rivalry within the Industry:
    High Threat: The bioinformatics market is highly competitive, with numerous well-established players vying for market share.
  • The bioinformatics market is poised for remarkable growth, driven by technological advancements, increasing research endeavors, and a burgeoning focus on personalized medicine.

Assisted Reproductive Technology Market Size is Projected to Hit USD 63.88 Billion, With at a 10.2% CAGR by 2029 | Brandessence Market Research

Retrieved on: 
木曜日, 9月 21, 2023
The Comprehensive Guide to Board Wargaming, Pregnancy, Prevalence, Disease, Diverticulitis, ART, Infertility, Fertilisation, IVF, EMA, Acquisition, Patient, Anemia, Fertility, HPV, Genetic testing, Alzheimer's disease, Research, FDA, Horizon, Epidemiology, Medical device, Birth control, Creative industries, Pharmaceutical industry, Vaccine, Assisted reproductive technology

Based on technology, the in-vitro fertilization is slated to dominate the market in terms of volume share.

Key Points: 
  • Based on technology, the in-vitro fertilization is slated to dominate the market in terms of volume share.
  • Europe Assisted Reproductive Technology Market:
    Europe is anticipated to lead the region in terms of revenue share.
  • Rapid advancements in genetic testing technologies are create a fertile ground for businesses to offer specialized genetic testing services within the Assisted Reproductive Technology Market.
  • The threat of new entrants in the Assisted Reproductive Technology Market is relatively low.

Assisted Reproductive Technology Market Size is Projected to Hit USD 63.88 Billion, With at a 10.2% CAGR by 2029 | Brandessence Market Research

Retrieved on: 
木曜日, 9月 21, 2023
The Comprehensive Guide to Board Wargaming, Pregnancy, Prevalence, Disease, Diverticulitis, ART, Infertility, Fertilisation, IVF, EMA, Acquisition, Patient, Anemia, Fertility, HPV, Genetic testing, Alzheimer's disease, Research, FDA, Horizon, Epidemiology, Medical device, Birth control, Creative industries, Pharmaceutical industry, Vaccine, Assisted reproductive technology

Based on technology, the in-vitro fertilization is slated to dominate the market in terms of volume share.

Key Points: 
  • Based on technology, the in-vitro fertilization is slated to dominate the market in terms of volume share.
  • Europe Assisted Reproductive Technology Market:
    Europe is anticipated to lead the region in terms of revenue share.
  • Rapid advancements in genetic testing technologies are create a fertile ground for businesses to offer specialized genetic testing services within the Assisted Reproductive Technology Market.
  • The threat of new entrants in the Assisted Reproductive Technology Market is relatively low.

Exploring Parkinson's Disease Statistics: Market Insight, Epidemiology ,Forecast Price and Market Access ,Commercial Strategy Analysis, Drug Development & Healthcare Consulting Services by Disease landscape Insights

Retrieved on: 
木曜日, 9月 14, 2023
Non-invasive ventilation, Health care, DSM-IV codes, Diverticulitis, Cerebrospinal fluid, Protein, Patient, Risk, Disease, Tremor, Genetics, Spinal cord, Gait abnormality, Genetic testing, Brain, Dopamine, Research, Approximation error, Magnetic resonance, Biomarker, Parkinson's disease, DLI, Diagnosis, Alzheimer's disease, FDA, Magnetic resonance imaging, Horizon, Safety, Exercise, Functional magnetic resonance imaging, DBS, Algorithm, Roger Hawkins (drummer), Research and development, Central nervous system, Clinical trial, Quality of life, Deep brain stimulation, Movement, MRI, L-DOPA, Scan (company), AI, Artificial intelligence, Pharmaceutical industry, Medical imaging, Medical device, Forestry, Dietary supplement

Advancements in Parkinson's Disease Diagnosis: Facilitating Patient Care

Key Points: 
  • Advancements in Parkinson's Disease Diagnosis: Facilitating Patient Care
    Parkinson's Disease can be challenging to diagnose, often leading to delayed treatment initiation.
  • However, recent advancements in diagnostic tools have empowered healthcare professionals to identify the disease more accurately and at earlier stages.
  • DiseaseLandscape Insights is at the forefront of drug insights and discovery, product launches, and clinical trial feasibility analysis in the fight against Parkinson's Disease.
  • The Parkinson's Disease Overview by healthcare consulting services provider DLI shows that it is competitive, with pharmaceutical companies vying to develop better treatments.